Texas House Bill HB1338

Texas 2019 - 86th Regular

Caption

Relating to prescribing low-THC cannabis to certain patients for compassionate use.

Impact

If enacted, the bill is expected to impact how healthcare professionals manage epilepsy in Texas, particularly by allowing certified physicians more authority to prescribe low-THC cannabis. This legislation is intended to improve patient access to alternative treatments that could alleviate seizure symptoms, thereby contributing to patient wellbeing. Additionally, it establishes a framework for physician collaboration, requiring a second physician to concur with the treatment plan before a prescription is filled, enhancing the safety and oversight of low-THC cannabis use in medical practice.

Summary

House Bill 1338 aims to amend the Occupations Code related to the prescription of low-THC cannabis for patients suffering from epilepsy. The bill expands the definition of epilepsy and clarifies the qualifications necessary for physicians to prescribe low-THC cannabis. Under this bill, a physician must be licensed, devote significant clinical practice to epilepsy treatment, and possess specific certifications related to neurology and epilepsy. These changes are designed to better facilitate access to low-THC cannabis for patients who are permanent residents and diagnosed with the condition.

Contention

One point of contention surrounding HB 1338 relates to the broader implications of prescribing low-THC cannabis. Some may argue that while the bill provides compassionate use provisions, it could open up debates about the appropriateness and safety of cannabis as a medical treatment. Opponents might express concerns surrounding the regulation of cannabis and whether the medical community is adequately equipped or trained to handle such prescriptions. However, supporters assert that this bill creates necessary patient-centered solutions for those affected by epilepsy, ensuring that they have access to potentially life-altering treatments.